Latest Insider Transactions at Cerevel Therapeutics Holdings, Inc. (CERE)
This section provides a real-time view of insider transactions for Cerevel Therapeutics Holdings, Inc. (CERE). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of Cerevel Therapeutics Holdings, Inc. to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of Cerevel Therapeutics Holdings, Inc.'s insiders and make more informed investment decisions.
Insider Transaction List
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Aug 01
2024
|
Pfizer Inc |
SELL
Disposition due to a tender of shares in a change of control transaction
|
Direct |
27,349,211
-100.0%
|
$1,230,714,495
$45.0 P/Share
|
|
Aug 01
2024
|
Christopher R Gordon |
SELL
Sale (or disposition) back to the issuer
|
Indirect |
65,679,781
-100.0%
|
-
|
|
Aug 01
2024
|
Christopher R Gordon |
SELL
Sale (or disposition) back to the issuer
|
Direct |
13,743
-61.94%
|
-
|
|
Aug 01
2024
|
Bain Capital Investors LLC |
SELL
Sale (or disposition) back to the issuer
|
Indirect |
65,679,781
-100.0%
|
-
|
|
Aug 01
2024
|
Adam Koppel |
SELL
Sale (or disposition) back to the issuer
|
Indirect |
65,679,781
-100.0%
|
-
|
|
Aug 01
2024
|
Adam Koppel |
SELL
Sale (or disposition) back to the issuer
|
Direct |
13,743
-61.94%
|
-
|
|
Aug 01
2024
|
Ronald C Renaud Jr President & CEO |
SELL
Sale (or disposition) back to the issuer
|
Indirect |
83,857
-100.0%
|
-
|
|
Aug 01
2024
|
Ronald C Renaud Jr President & CEO |
SELL
Sale (or disposition) back to the issuer
|
Direct |
160,452
-100.0%
|
-
|
|
Aug 01
2024
|
Douglas E. Giordano |
SELL
Sale (or disposition) back to the issuer
|
Direct |
13,743
-61.94%
|
-
|
|
Aug 01
2024
|
Ramiro Sanchez Chief Medical Officer |
SELL
Sale (or disposition) back to the issuer
|
Direct |
14,673
-100.0%
|
-
|
|
Aug 01
2024
|
Kathleen Tregoning |
SELL
Sale (or disposition) back to the issuer
|
Direct |
10,666
-100.0%
|
-
|
|
Aug 01
2024
|
Kenneth Di Pietro Chief Human Resources Officer |
SELL
Sale (or disposition) back to the issuer
|
Direct |
25,042
-100.0%
|
-
|
|
Aug 01
2024
|
John Renger Chief Scientific Officer |
SELL
Sale (or disposition) back to the issuer
|
Direct |
6,370
-100.0%
|
-
|
|
Aug 01
2024
|
Gabrielle Sulzberger |
SELL
Sale (or disposition) back to the issuer
|
Direct |
58,876
-91.12%
|
-
|
|
Aug 01
2024
|
Scott Akamine Chief Legal Officer |
SELL
Sale (or disposition) back to the issuer
|
Direct |
7,527
-100.0%
|
-
|
|
Aug 01
2024
|
Ruth Mckernan |
SELL
Sale (or disposition) back to the issuer
|
Direct |
13,743
-61.94%
|
-
|
|
Aug 01
2024
|
Norbert G Riedel |
SELL
Sale (or disposition) back to the issuer
|
Direct |
56,553
-90.75%
|
-
|
|
Aug 01
2024
|
Susan Altschuller Chief Financial Officer |
SELL
Sale (or disposition) back to the issuer
|
Direct |
16,913
-100.0%
|
-
|
|
Aug 01
2024
|
Marijn E Dekkers |
SELL
Sale (or disposition) back to the issuer
|
Indirect |
402,326
-100.0%
|
-
|
|
Aug 01
2024
|
Marijn E Dekkers |
SELL
Sale (or disposition) back to the issuer
|
Direct |
42,283
-87.63%
|
-
|
|
Aug 01
2024
|
Paul D. Burgess |
SELL
Sale (or disposition) back to the issuer
|
Direct |
45,727
-100.0%
|
-
|
|
Aug 01
2024
|
N Anthony Coles |
SELL
Sale (or disposition) back to the issuer
|
Direct |
25,928
-80.16%
|
-
|
|
Aug 01
2024
|
Deval L Patrick |
SELL
Sale (or disposition) back to the issuer
|
Direct |
13,743
-61.94%
|
-
|
|
Aug 01
2024
|
Mark Bodenrader |
SELL
Sale (or disposition) back to the issuer
|
Direct |
17,724
-100.0%
|
-
|
|
Jul 01
2024
|
N Anthony Coles |
SELL
Open market or private sale
|
Direct |
25,000
-49.09%
|
$1,025,000
$41.18 P/Share
|
|
Jul 01
2024
|
N Anthony Coles |
BUY
Exercise of conversion of derivative security
|
Direct |
25,000
+32.93%
|
$75,000
$3.5 P/Share
|
|
Jun 05
2024
|
Christopher R Gordon |
BUY
Grant, award, or other acquisition
|
Direct |
10,461
+43.22%
|
-
|
|
Jun 05
2024
|
Adam Koppel |
BUY
Grant, award, or other acquisition
|
Direct |
10,461
+43.22%
|
-
|
|
Jun 05
2024
|
Douglas E. Giordano |
BUY
Grant, award, or other acquisition
|
Direct |
10,461
+43.22%
|
-
|
|
Jun 05
2024
|
Norbert G Riedel |
BUY
Grant, award, or other acquisition
|
Direct |
10,461
+15.61%
|
-
|
|
Jun 05
2024
|
Deval L Patrick |
BUY
Grant, award, or other acquisition
|
Direct |
10,461
+43.22%
|
-
|
|
Jun 05
2024
|
Marijn E Dekkers |
BUY
Grant, award, or other acquisition
|
Direct |
10,461
+19.83%
|
-
|
|
Jun 05
2024
|
N Anthony Coles |
BUY
Grant, award, or other acquisition
|
Direct |
10,290
+28.41%
|
-
|
|
Jun 05
2024
|
Ruth Mckernan |
BUY
Grant, award, or other acquisition
|
Direct |
10,461
+43.22%
|
-
|
|
Jun 05
2024
|
Gabrielle Sulzberger |
BUY
Grant, award, or other acquisition
|
Direct |
10,461
+15.09%
|
-
|
|
Jun 03
2024
|
N Anthony Coles |
SELL
Open market or private sale
|
Direct |
50,000
-76.18%
|
$2,000,000
$40.61 P/Share
|
|
Jun 03
2024
|
N Anthony Coles |
BUY
Exercise of conversion of derivative security
|
Direct |
50,000
+43.24%
|
$150,000
$3.5 P/Share
|
|
May 10
2024
|
N Anthony Coles |
SELL
Open market or private sale
|
Direct |
50,000
-76.18%
|
$2,100,000
$42.1 P/Share
|
|
May 10
2024
|
N Anthony Coles |
BUY
Exercise of conversion of derivative security
|
Direct |
50,000
+43.24%
|
$150,000
$3.5 P/Share
|
|
Apr 01
2024
|
N Anthony Coles |
SELL
Open market or private sale
|
Direct |
50,000
-76.18%
|
$2,100,000
$42.33 P/Share
|
|
Apr 01
2024
|
N Anthony Coles |
BUY
Exercise of conversion of derivative security
|
Direct |
50,000
+43.24%
|
$150,000
$3.5 P/Share
|
|
Mar 04
2024
|
N Anthony Coles |
SELL
Open market or private sale
|
Direct |
50,000
-76.18%
|
$2,050,000
$41.01 P/Share
|
|
Mar 04
2024
|
N Anthony Coles |
BUY
Exercise of conversion of derivative security
|
Direct |
50,000
+43.24%
|
$150,000
$3.5 P/Share
|
|
Feb 29
2024
|
N Anthony Coles |
SELL
Open market or private sale
|
Direct |
50,000
-76.18%
|
$2,050,000
$41.16 P/Share
|
|
Feb 29
2024
|
N Anthony Coles |
BUY
Exercise of conversion of derivative security
|
Direct |
50,000
+43.24%
|
$150,000
$3.5 P/Share
|
|
Feb 20
2024
|
Perceptive Advisors LLC Director |
SELL
Bona fide gift
|
Indirect |
170,317
-100.0%
|
-
|
|
Feb 07
2024
|
N Anthony Coles |
SELL
Open market or private sale
|
Direct |
2,506
-13.81%
|
$102,746
$41.54 P/Share
|
|
Feb 07
2024
|
John Renger Chief Scientific Officer |
SELL
Open market or private sale
|
Direct |
2,161
-25.33%
|
$88,601
$41.54 P/Share
|
|
Feb 06
2024
|
N Anthony Coles |
BUY
Exercise of conversion of derivative security
|
Direct |
15,440
+45.97%
|
-
|
|
Feb 06
2024
|
John Renger Chief Scientific Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
5,020
+37.05%
|
-
|